Your search
Results 3 resources
-
Life Cycle Assessment (LCA) is a foundational method for quantitative assessment of sustainability. Increasing data availability and rapid development of machine learning (ML) approaches offer new opportunities to advance LCA. Here, we review current progress and knowledge gaps in applying ML techniques to support LCA, and identify future research directions for LCAs to better harness the power of ML. This review analyzes forty studies reporting quantitative assessment with a combination of LCA and ML methods. We found that ML approaches have been used for generating life cycle inventories, computing characterization factors, estimating life cycle impacts, and supporting life cycle interpretation. Most of the reviewed studies employed a single ML method, with artificial neural networks (ANNs) as the most frequently applied approach. Both supervised and unsupervised ML techniques were used in LCA studies. For studies using supervised ML, training datasets were derived from diverse sources, such as literature, lab experiments, existing databases, and model simulations. Over 70 % of these reviewed studies trained ML models with less than 1500 sample datasets. Although these reviewed studies showed that ML approaches help improve prediction accuracy, pattern discovery and computational efficiency, multiple areas deserve further research. First, continuous data collection and compilation is needed to support more reliable ML and LCA modeling. Second, future studies should report sufficient details regarding the selection criteria for ML models and present model uncertainty analysis. Third, incorporating deep learning models into LCA holds promise to further improve life cycle inventory and impact assessment. Finally, the complexity of current environmental challenges calls for interdisciplinary collaborative research to achieve deep integration of ML into LCA to support sustainable development.
-
Human mesenchymal stem cells (hMSCs) are multipotent progenitor cells with the potential to differentiate into various cell types, including osteoblasts, chondrocytes, and adipocytes. These cells have been extensively employed in the field of cell-based therapies and regenerative medicine due to their inherent attributes of self-renewal and multipotency. Traditional approaches for assessing hMSCs differentiation capacity have relied heavily on labor-intensive techniques, such as RT-PCR, immunostaining, and Western blot, to identify specific biomarkers. However, these methods are not only time-consuming and economically demanding, but also require the fixation of cells, resulting in the loss of temporal data. Consequently, there is an emerging need for a more efficient and precise approach to predict hMSCs differentiation in live cells, particularly for osteogenic and adipogenic differentiation. In response to this need, we developed innovative approaches that combine live-cell imaging with cutting-edge deep learning techniques, specifically employing a convolutional neural network (CNN) to meticulously classify osteogenic and adipogenic differentiation. Specifically, four notable pre-trained CNN models, VGG 19, Inception V3, ResNet 18, and ResNet 50, were developed and tested for identifying adipogenic and osteogenic differentiated cells based on cell morphology changes. We rigorously evaluated the performance of these four models concerning binary and multi-class classification of differentiated cells at various time intervals, focusing on pivotal metrics such as accuracy, the area under the receiver operating characteristic curve (AUC), sensitivity, precision, and F1-score. Among these four different models, ResNet 50 has proven to be the most effective choice with the highest accuracy (0.9572 for binary, 0.9474 for multi-class) and AUC (0.9958 for binary, 0.9836 for multi-class) in both multi-class and binary classification tasks. Although VGG 19 matched the accuracy of ResNet 50 in both tasks, ResNet 50 consistently outperformed it in terms of AUC, underscoring its superior effectiveness in identifying differentiated cells. Overall, our study demonstrated the capability to use a CNN approach to predict stem cell fate based on morphology changes, which will potentially provide insights for the application of cell-based therapy and advance our understanding of regenerative medicine.
-
Whole-body dynamic fluoro-D-glucose (FDG)-positron emission tomography (PET) imaging through continuous-bed-motion (CBM) mode multi-pass acquisition protocol is a promising metabolism measurement. However, inter-pass misalignment originating from body movement could degrade parametric quantification. We aim to apply a non-rigid registration method for inter-pass motion correction in whole-body dynamic PET. 27 subjects underwent a 90-min whole-body FDG CBM PET scan on a Biograph mCT (Siemens Healthineers), acquiring 9 over-the-heart single-bed passes and subsequently 19 CBM passes (frames). The inter-pass motion correction was executed using non-rigid image registration with multi-resolution, B-spline free-form deformations. The parametric images were then generated by Patlak analysis. The overlaid Patlak slope Ki and y-intercept Vb images were visualized to qualitatively evaluate motion impact and correction effect. The normalized weighted mean-squared Patlak fitting errors (NFEs) were compared in the whole body, head, and hypermetabolic regions of interest (ROIs). In Ki images, ROI statistics were collected and malignancy discrimination capacity was estimated by the area under the receiver operating characteristic curve (AUC). After the inter-pass motion correction was applied, the spatial misalignment appearance between Ki and Vb images was successfully reduced. Voxel-wise normalized fitting error maps showed global error reduction after motion correction. The NFE in the whole body ( p \,\,= 0.0013), head ( p \,\,= 0.0021), and ROIs ( p \,\,= 0.0377) significantly decreased. The visual performance of each hypermetabolic ROI in Ki images was enhanced, while 3.59% and 3.67% average absolute percentage changes were observed in mean and maximum Ki values, respectively, across all evaluated ROIs. The estimated mean Ki values had substantial changes with motion correction ( p \,\,= 0.0021). The AUC of both mean Ki and maximum Ki after motion correction increased, possibly suggesting the potential of enhancing oncological discrimination capacity through inter-pass motion correction.
Explore
Resource type
- Journal Article (3)